De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

Oceania Healthcare Toekomstige groei

Future criteriumcontroles 4/6

Oceania Healthcare zal naar verwachting groeien in winst en omzet met respectievelijk 26.2% en 8.9% per jaar. De winst per aandeel zal naar verwachting groeien met 30.6% per jaar. Het rendement op het eigen vermogen zal over 3 jaar naar verwachting 7.3% zijn.

Belangrijke informatie

26.2%

Groei van de winst

30.6%

Groei van de winst per aandeel

Healthcare winstgroei	10.5%
Inkomstengroei	8.9%
Toekomstig rendement op eigen vermogen	7.3%
Dekking van analisten	Low
Laatst bijgewerkt	24 Sep 2024

Recente toekomstige groei-updates

Recent updates

Oceania Healthcare Limited (NZSE:OCA) Stock Rockets 31% But Many Are Still Ignoring The Company

Jul 22

Oceania Healthcare Limited's (NZSE:OCA) CEO Might Not Expect Shareholders To Be So Generous This Year

Jun 20

Oceania Healthcare Limited's (NZSE:OCA) Intrinsic Value Is Potentially 75% Above Its Share Price

Aug 02

Oceania Healthcare (NZSE:OCA) Is Paying Out A Larger Dividend Than Last Year

May 23

Calculating The Intrinsic Value Of Oceania Healthcare Limited (NZSE:OCA)

Jan 24

Factors Income Investors Should Consider Before Adding Oceania Healthcare Limited (NZSE:OCA) To Their Portfolio

May 04

Oceania Healthcare Limited's (NZSE:OCA) Intrinsic Value Is Potentially 50% Above Its Share Price

Mar 23

Does Oceania Healthcare (NZSE:OCA) Have A Healthy Balance Sheet?

Feb 25

It Might Not Be A Great Idea To Buy Oceania Healthcare Limited (NZSE:OCA) For Its Next Dividend

Feb 04

If You Had Bought Oceania Healthcare (NZSE:OCA) Shares Three Years Ago You'd Have Earned 39% Returns

Jan 17

Read This Before Buying Oceania Healthcare Limited (NZSE:OCA) For Its Dividend

Dec 27

Is There An Opportunity With Oceania Healthcare Limited's (NZSE:OCA) 32% Undervaluation?

Nov 30

Winst- en omzetgroeiprognoses

NZSE:OCA - Toekomstschattingen van analisten en financiële gegevens uit het verleden (NZD Millions )
Datum	Inkomsten	Inkomsten	Vrije kasstroom	Geldmiddelen uit operationele activiteiten	Gem. Aantal analisten
3/31/2027	348	106	N/A	N/A	3
3/31/2026	329	93	N/A	N/A	3
3/31/2025	301	64	N/A	N/A	3
3/31/2024	265	31	32	85	N/A
12/31/2023	261	35	68	86	N/A
9/30/2023	257	39	103	87	N/A
6/30/2023	252	27	59	79	N/A
3/31/2023	247	15	14	70	N/A
12/31/2022	243	25	14	77	N/A
9/30/2022	238	35	13	84	N/A
6/30/2022	235	48	31	95	N/A
3/31/2022	231	61	49	106	N/A
3/31/2021	213	103	72	115	N/A
11/30/2020	203	-4	80	117	N/A
8/31/2020	200	-9	69	108	N/A
5/31/2020	196	-14	59	99	N/A
2/29/2020	193	23	51	99	N/A
11/30/2019	191	59	43	99	N/A
8/31/2019	190	52	30	94	N/A
5/31/2019	189	45	16	89	N/A
2/28/2019	189	41	34	101	N/A
11/30/2018	188	36	52	112	N/A
8/31/2018	186	56	51	97	N/A
5/31/2018	184	77	49	82	N/A
2/28/2018	180	71	N/A	63	N/A
11/30/2017	176	65	N/A	43	N/A
8/31/2017	175	55	N/A	41	N/A
5/31/2017	174	45	N/A	39	N/A
5/31/2016	173	49	N/A	40	N/A
5/31/2015	171	19	N/A	30	N/A
5/31/2014	173	-31	N/A	33	N/A

Toekomstige groeivoorspellingen analisten

Verdiensten versus spaarpercentage: De verwachte winstgroei OCA ( 26.2% per jaar) ligt boven de spaarquote ( 2.8% ).

Winst versus markt: De winst van OCA ( 26.2% per jaar) zal naar verwachting sneller groeien dan de NZ markt ( 18% per jaar).

Hoge groeiwinsten: De winst van OCA zal naar verwachting de komende 3 jaar aanzienlijk groeien.

Omzet versus markt: De omzet van OCA ( 8.9% per jaar) zal naar verwachting sneller groeien dan de markt NZ ( 4.1% per jaar).

Hoge groei-inkomsten: De omzet van OCA ( 8.9% per jaar) zal naar verwachting langzamer groeien dan 20% per jaar.

Groeiprognoses winst per aandeel

Toekomstig rendement op eigen vermogen

Toekomstige ROE: Het rendement op eigen vermogen OCA zal naar verwachting over 3 jaar laag zijn ( 7.3 %).

Oceania Healthcare Toekomstige groei

Future criteriumcontroles 4/6

Belangrijke informatie

Recente toekomstige groei-updates

Consensus EPS estimates increase by 33%

Consensus EPS estimates fall by 28%

Consensus EPS estimates increase by 49%

Price target decreased by 7.1% to NZ$1.15

Price target decreased by 9.6% to NZ$1.15

Price target decreased to NZ$1.31

Recent updates

Insufficient new directors

Oceania Healthcare Limited (NZSE:OCA) Stock Rockets 31% But Many Are Still Ignoring The Company

Now 23% overvalued after recent price rise

Oceania Healthcare Limited Resolves Not to Pay a Final Dividend

Oceania Healthcare Limited's (NZSE:OCA) CEO Might Not Expect Shareholders To Be So Generous This Year

Oceania Healthcare's (NZSE:OCA) Earnings Are Of Questionable Quality

Full year 2024 earnings: EPS and revenues miss analyst expectations

Oceania Healthcare Limited, Annual General Meeting, Jun 27, 2024

Oceania Healthcare Limited Announces Appointment of Claire Fisher as Group General Counsel and Company Secretary, Effective from January 2024

Oceania Healthcare Appoints Tracey Taylor as Chief People Officer

First half 2024 earnings released: EPS: NZ$0.049 (vs NZ$0.016 in 1H 2023)

Consensus EPS estimates increase by 33%

Oceania Healthcare Limited Resolves Not to Pay an Interim Dividend

Oceania Healthcare Limited Approves Dividend Policy

Consensus EPS estimates fall by 28%

Oceania Healthcare Limited, Annual General Meeting, Aug 25, 2023

Upcoming dividend of NZ$0.013 per share at 5.6% yield

Oceania Healthcare Limited Announces Distribution on Oca - Ordinary Fully Paid Foreign Exempt Nzx Relates to A Period of Twelve Months Ended March 31, 2023

Consensus EPS estimates increase by 49%

Be Wary Of Oceania Healthcare (NZSE:OCA) And Its Returns On Capital

Price target decreased by 7.1% to NZ$1.15

Price target decreased by 9.6% to NZ$1.15

Now 21% undervalued after recent price drop

Now 21% undervalued after recent price drop

Calculating The Fair Value Of Oceania Healthcare Limited (NZSE:OCA)

Oceania Announces Resignation of Frances Hughes as Group General Manager Clinical and Care Services

Now 20% undervalued after recent price drop

Oceania Healthcare (NZSE:OCA) Is Paying Out Less In Dividends Than Last Year

Oceania Healthcare Limited Declares Interim Dividend, Payable on December 14, 2022

First half 2023 earnings released: EPS: NZ$0.016 (vs NZ$0.043 in 1H 2022)

Price target decreased to NZ$1.31

Oceania Healthcare Limited Announces Total Cash Distribution on Retained Earnings, Payable on December 14, 2022

Consensus forecasts updated

Oceania Healthcare Limited Announces Total Cash Distribution on Retained Earnings, Payable on December 14, 2022

Oceania Healthcare Limited's (NZSE:OCA) Intrinsic Value Is Potentially 75% Above Its Share Price

Consensus forecasts updated

Independent Chairperson recently bought NZ$51k worth of stock

Upcoming dividend of NZ$0.023 per share

Oceania Healthcare (NZSE:OCA) Is Paying Out A Larger Dividend Than Last Year

Full year 2022 earnings: EPS and revenues miss analyst expectations

Oceania Healthcare Limited Announces Final Dividend, Payable on June 21, 2022

Oceania Healthcare Limited, Annual General Meeting, Jun 23, 2022

Oceania Healthcare Limited to Report Fiscal Year 2022 Results on May 20, 2022

Now 20% undervalued after recent price drop

Calculating The Intrinsic Value Of Oceania Healthcare Limited (NZSE:OCA)

Consensus forecasts updated

Independent Chairperson recently bought NZ$66k worth of stock

Consensus forecasts updated

Insider recently sold NZ$1.5m worth of stock

Insider recently bought NZ$272k worth of stock

Insider recently sold NZ$209k worth of stock

General Manager of Sales recently sold NZ$446k worth of stock

Upcoming dividend of NZ$0.012 per share

Oceania Healthcare Limited Declares Final Dividend for the 10 Month Period to 31 March 2021, Payable on 22 June 2021

Factors Income Investors Should Consider Before Adding Oceania Healthcare Limited (NZSE:OCA) To Their Portfolio

Price target increased to NZ$1.75

Insider recently bought NZ$354k worth of stock

Oceania Healthcare Limited's (NZSE:OCA) Intrinsic Value Is Potentially 50% Above Its Share Price

Oceania Healthcare Limited Announces Executive Changes

Does Oceania Healthcare (NZSE:OCA) Have A Healthy Balance Sheet?

It Might Not Be A Great Idea To Buy Oceania Healthcare Limited (NZSE:OCA) For Its Next Dividend

Insider recently sold NZ$1.0m worth of stock

Price target raised to NZ$1.54

New 90-day high: NZ$1.52

First half 2021 earnings released: EPS NZ$0.04

If You Had Bought Oceania Healthcare (NZSE:OCA) Shares Three Years Ago You'd Have Earned 39% Returns

New 90-day high: NZ$1.48

Read This Before Buying Oceania Healthcare Limited (NZSE:OCA) For Its Dividend

New 90-day high: NZ$1.41